Seafood types and age-related cognitive decline in the Women's Health Study.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3779629)

Published in J Gerontol A Biol Sci Med Sci on April 03, 2013

Authors

Dae Hyun Kim1, Francine Grodstein, Bernard Rosner, Jae H Kang, Nancy R Cook, Joann E Manson, Julie E Buring, Walter C Willett, Olivia I Okereke

Author Affiliations

1: SM, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115. olivia.okereke@channing.harvard.edu.

Articles cited by this

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09

Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02

Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA (2006) 7.73

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56

Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids (2001) 3.49

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24

Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron (2004) 3.21

A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med (2006) 3.19

Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68

Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol (2006) 2.16

Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev (2012) 1.82

Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr (2007) 1.74

Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology (2004) 1.73

Fish consumption and cognitive decline with age in a large community study. Arch Neurol (2005) 1.71

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology (2005) 1.62

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement (2010) 1.62

Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci (2000) 1.56

Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project. J Gerontol (1993) 1.47

Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. Am J Clin Nutr (2007) 1.38

Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med (2005) 1.35

Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34

Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids (2009) 1.15

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci (2012) 1.04

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr (2009) 1.02

Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids (2006) 1.02

Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr (2011) 0.96

Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement (2011) 0.94

Long-term reproducibility of a food-frequency questionnaire and dietary changes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr (2007) 0.92

Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res (2009) 0.92

Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models. Neurochem Int (2011) 0.92

High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J Nutr Health Aging (2011) 0.91

Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. J Nutr (2009) 0.88

Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health (2006) 0.88

Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res (2011) 0.87

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry (2006) 0.85

The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.83

Selenium and cognitive impairment: a brief-review based on results from the EVA study. Biofactors (2012) 0.79

Articles by these authors

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68

Statins: new American guidelines for prevention of cardiovascular disease. Lancet (2013) 9.56

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med (2005) 8.73

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ (2007) 7.54

The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med (2012) 6.46

Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA (2008) 5.92

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74

The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28

Physical activity and weight gain prevention. JAMA (2010) 5.27

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med (2005) 4.92

Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med (1990) 4.77

Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA (2011) 4.75

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA (2004) 4.47

Association between a literature-based genetic risk score and cardiovascular events in women. JAMA (2010) 4.46

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46

Physical activity at midlife in relation to successful survival in women at age 70 years or older. Arch Intern Med (2010) 4.45

Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem (2007) 4.45